Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

Vitter Introduces Bill to Protect Access to Life-Saving Medications

Monday, June 15, 2015   (0 Comments)
Posted by: Dagmar Anderson
Share |


 

For Immediate Release                                 Contact: Lindsay Bembenek

           June 9, 2015                                                     (202) 224-4623

 

Vitter Introduces Bill to Protect Access to Life-Saving Medications

Legislation would expand access to special medications used to treat pediatric cancer, autism, and other conditions

 

(Washington, D.C.) – U.S. Senator David Vitter (R-La.) today announced that he has introduced legislation to protect and expand access to life-saving compounded medications. Compounded medications are used to treat patients with unique medical conditions that make them resistant to standard medications, such as pediatric cancer patients. Vitter’s legislation, the Saving Access to Compounded Medications for Special Needs Patients Act, would ensure that patients have access to the custom medications they need.

 

“Compounded medications often go to the most vulnerable patients, like cancer patients and children with special needs. Our children’s health and safety need to be our very top priority, and Louisiana families shouldn’t have to drive to Texas to get life-saving medications,” Vitter said. “FDA overreach is jeopardizing access to these medications, and my legislation would make sure patients and families can get the medicines they need as quickly as possible.”

 

Due to Food and Drug Administration (FDA) regulations, states such as Louisiana have had to limit interstate and intrastate access to compounded medication, cutting off access to these medications for patients with unique medical needs. For example, custom compounded medications are commonly used to treat children with cancer and autism because the dosage strength they need for life-saving medicines varies from standard medications.

 

Vitter’s legislation would expand access to these medications by allowing pharmacists to distribute compounded medication to a licensed practitioner for administration without a patient-specific prescription. It would allow them to prescribe compounded prescriptions in an in-office setting and add protections for distributing patient-specific medications both within a state and across state lines. His legislation also strengthens safety standards by requiring all compounded drugs to comply with United States Pharmacopeial (USP) standards.

 

-30-

 


Association Management Software Powered by YourMembership.com®  ::  Legal